PL3230479T3 - Szczepy probiotyczne posiadające zdolność do wchłaniania cholesterolu, ich metody i zastosowania - Google Patents
Szczepy probiotyczne posiadające zdolność do wchłaniania cholesterolu, ich metody i zastosowaniaInfo
- Publication number
- PL3230479T3 PL3230479T3 PL15808180T PL15808180T PL3230479T3 PL 3230479 T3 PL3230479 T3 PL 3230479T3 PL 15808180 T PL15808180 T PL 15808180T PL 15808180 T PL15808180 T PL 15808180T PL 3230479 T3 PL3230479 T3 PL 3230479T3
- Authority
- PL
- Poland
- Prior art keywords
- methods
- absorbing capacity
- probiotic strains
- cholesterol
- cholesterol absorbing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14384202.9A EP3031930A1 (en) | 2014-12-10 | 2014-12-10 | Probiotic strains having cholesterol absorbing capacity, methods and uses thereof |
PCT/EP2015/079298 WO2016092032A1 (en) | 2014-12-10 | 2015-12-10 | Probiotic strains having cholesterol absorbing capacity, methods and uses thereof |
EP15808180.2A EP3230479B1 (en) | 2014-12-10 | 2015-12-10 | Probiotic strains having cholesterol absorbing capacity, methods and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3230479T3 true PL3230479T3 (pl) | 2022-05-09 |
Family
ID=52396401
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL15808180T PL3230479T3 (pl) | 2014-12-10 | 2015-12-10 | Szczepy probiotyczne posiadające zdolność do wchłaniania cholesterolu, ich metody i zastosowania |
Country Status (14)
Country | Link |
---|---|
US (1) | US11058734B2 (pl) |
EP (2) | EP3031930A1 (pl) |
JP (1) | JP6707087B2 (pl) |
CN (1) | CN107438664B (pl) |
AU (1) | AU2015359382B2 (pl) |
BR (1) | BR112017012251A2 (pl) |
CA (1) | CA2970602C (pl) |
ES (1) | ES2899185T3 (pl) |
HU (1) | HUE057081T2 (pl) |
MX (1) | MX2017007654A (pl) |
PL (1) | PL3230479T3 (pl) |
RS (1) | RS62610B1 (pl) |
RU (1) | RU2722038C2 (pl) |
WO (1) | WO2016092032A1 (pl) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106434427A (zh) * | 2016-08-29 | 2017-02-22 | 中国疾病预防控制中心传染病预防控制所 | 乳酸杆菌益生菌cgmcc no.12421及在制备降脂药物中的应用 |
WO2018065132A1 (en) * | 2016-10-04 | 2018-04-12 | Institut National De La Recherche Agronomique | Use of ahr agonist for the preventive or curative treatment of metabolic syndrome and the associated disorders. |
EP3634439A4 (en) * | 2017-06-09 | 2021-04-07 | Sami Labs Limited | HYPOLIPIDEMIC EFFECTS OF BACILLUS COAGULANS |
EP3777868A4 (en) * | 2018-03-23 | 2021-12-01 | Morinaga Milk Industry Co., Ltd. | COMPOSITION FOR INFANTS INTENDED TO PREVENT DISEASES CAUSED BY HYPERGLYCEMIA FROM SCHOOL AGE |
CN112646832B (zh) * | 2020-12-25 | 2022-06-21 | 上海理工大学 | 一种调节植物乳杆菌黏附能力的方法 |
CN114344344B (zh) * | 2022-01-05 | 2023-06-13 | 东北农业大学 | 罗伊氏乳杆菌在缓解高脂饮食诱导小鼠肥胖功能中的应用及含有罗伊氏乳杆菌的复合物 |
US20240245746A1 (en) * | 2023-01-19 | 2024-07-25 | Tci Co., Ltd. | Method for regulating immunity by using black hulless barley extract |
CN116121146B (zh) * | 2023-03-09 | 2024-01-30 | 四川大学 | 一株产乳酸能力较强的戊糖片球菌及其应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3777296B2 (ja) * | 2000-09-04 | 2006-05-24 | 明治製菓株式会社 | 乳酸菌によるコレステロールの低減若しくは除去方法 |
AU2001293031A1 (en) * | 2000-09-25 | 2002-04-08 | Michael Dean | Gene involved in dietary sterol absorption and excretion and uses therefor |
EP1639108A2 (en) * | 2003-02-28 | 2006-03-29 | McGILL UNIVERSITY | Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides |
KR100691863B1 (ko) * | 2004-12-07 | 2007-03-13 | 김홍렬 | 비피도박테리움 비피둠의 공배양을 통한 콜레스테롤 흡수 저하방법 및 이를 이용한 콜레스테롤 저하제 |
JP4662443B2 (ja) * | 2005-02-14 | 2011-03-30 | 明治乳業株式会社 | コレステロール低減乳酸菌 |
JP4336992B2 (ja) * | 2006-01-20 | 2009-09-30 | 日清食品ホールディングス株式会社 | 血中コレステロール低減作用を有する新規乳酸菌 |
EP2311473A1 (en) * | 2009-10-09 | 2011-04-20 | AB-Biotics Producciones Industriales De Microbiotas, S.L. | Lactobacillus plantarum strains as probiotics |
CN102028713A (zh) * | 2010-12-12 | 2011-04-27 | 夏学德 | 一种用于降低血清胆固醇的益生菌制剂及其制备方法 |
ITMI20110792A1 (it) * | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia. |
-
2014
- 2014-12-10 EP EP14384202.9A patent/EP3031930A1/en not_active Withdrawn
-
2015
- 2015-12-10 RU RU2017121227A patent/RU2722038C2/ru active
- 2015-12-10 EP EP15808180.2A patent/EP3230479B1/en active Active
- 2015-12-10 US US15/534,059 patent/US11058734B2/en active Active
- 2015-12-10 ES ES15808180T patent/ES2899185T3/es active Active
- 2015-12-10 BR BR112017012251-0A patent/BR112017012251A2/pt active Search and Examination
- 2015-12-10 PL PL15808180T patent/PL3230479T3/pl unknown
- 2015-12-10 HU HUE15808180A patent/HUE057081T2/hu unknown
- 2015-12-10 JP JP2017531780A patent/JP6707087B2/ja not_active Expired - Fee Related
- 2015-12-10 MX MX2017007654A patent/MX2017007654A/es unknown
- 2015-12-10 CN CN201580074875.9A patent/CN107438664B/zh active Active
- 2015-12-10 RS RS20211455A patent/RS62610B1/sr unknown
- 2015-12-10 CA CA2970602A patent/CA2970602C/en active Active
- 2015-12-10 WO PCT/EP2015/079298 patent/WO2016092032A1/en active Application Filing
- 2015-12-10 AU AU2015359382A patent/AU2015359382B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
MX2017007654A (es) | 2018-05-04 |
ES2899185T8 (es) | 2022-05-26 |
JP2018503367A (ja) | 2018-02-08 |
US11058734B2 (en) | 2021-07-13 |
CA2970602C (en) | 2024-03-12 |
CA2970602A1 (en) | 2016-06-16 |
CN107438664B (zh) | 2021-07-30 |
RU2017121227A3 (pl) | 2019-05-28 |
US20170333495A1 (en) | 2017-11-23 |
JP6707087B2 (ja) | 2020-06-10 |
AU2015359382B2 (en) | 2021-09-02 |
ES2899185T3 (es) | 2022-03-10 |
EP3230479B1 (en) | 2021-10-06 |
EP3230479A1 (en) | 2017-10-18 |
RU2017121227A (ru) | 2019-01-10 |
RU2722038C2 (ru) | 2020-05-26 |
HUE057081T2 (hu) | 2022-04-28 |
CN107438664A (zh) | 2017-12-05 |
RS62610B1 (sr) | 2021-12-31 |
EP3031930A1 (en) | 2016-06-15 |
BR112017012251A2 (pt) | 2018-01-30 |
AU2015359382A1 (en) | 2017-07-27 |
WO2016092032A1 (en) | 2016-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL304772A (en) | Antibodies, uses and methods | |
ZA201704117B (en) | Cd47 antibodies, methods, and uses | |
HK1232140A1 (zh) | 微類器官以及製造和使用它們的方法 | |
PL3194567T3 (pl) | Probiotyczne szczepy bifidobacterium adolescentis | |
EP3223835A4 (en) | Intestinal microbiota and gvhd | |
SG10202109444TA (en) | Bendable glass stack assemblies, articles and methods of making the same | |
EP3229945A4 (en) | Graphene oxide membranes and methods related thereto | |
EP3102681A4 (en) | Trifunctional t cell-antigen coupler and methods and uses thereof | |
HUE057081T2 (hu) | Koleszterin abszorbeáló kapacitással rendelkezõ probiotikus törzsek, illetve ezek eljárásai és felhasználása | |
HUE044571T2 (hu) | Módosított ciklopentapeptidek és alkalmazásaik | |
PL2777405T3 (pl) | Nowe szczepy lactobacillus i ich zastosowania | |
ZA201608162B (en) | Wear indication devices, and related assemblies and methods | |
EP3110895A4 (en) | Polysilocarb materials, methods and uses | |
SG11201609490QA (en) | Polymer-flavonoid conjugate and uses thereof | |
SG11201704473WA (en) | New methods and uses | |
HK1258693A1 (zh) | 高容量,封閉,冷凍保存細胞庫系統及其用途 | |
PT3131577T (pt) | Células hospedeiras modificadas e suas utilizações | |
PL3040062T3 (pl) | Struktura chłonna i artykuł chłonny, zawierający tę strukturę chłonną | |
ZA201605290B (en) | Hybrid bw-type mushroom strains and lines and methods and uses therefor | |
HK1215786A1 (zh) | 充氣墊氣室,及充氣墊 | |
EP3112780A4 (en) | Accumulator, and refrigeration device with said accumulator | |
HUE044750T2 (hu) | CaCO3 oldó baktériumtörzsek és gombák | |
GB201408091D0 (en) | Methods and uses | |
PL3237600T3 (pl) | Termostabilne szczepy, ich produkty i sposoby stosowania | |
IL249073B (en) | Cytin-glucan complex, its preparation and uses |